Klotho Neurosciences (NASDAQ:KLTO) Releases Earnings Results

Klotho Neurosciences (NASDAQ:KLTO) posted its quarterly earnings results on Monday. The company reported ($0.07) EPS for the quarter, Zacks reports.

Klotho Neurosciences Trading Up 1.1 %

Shares of NASDAQ:KLTO traded up $0.00 during midday trading on Monday, hitting $0.23. The stock had a trading volume of 55,642 shares, compared to its average volume of 739,279. The stock has a 50-day moving average price of $0.34. Klotho Neurosciences has a fifty-two week low of $0.21 and a fifty-two week high of $13.10.

Klotho Neurosciences Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.